Status:
COMPLETED
Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis
Lead Sponsor:
Pfizer
Conditions:
Atopic Dermatitis
Plaque Psoriasis
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This study is being conducted to provide data on efficacy, safety, tolerability and PK of PF-07038124 ointment versus vehicle control in the treatment of mild to moderate AD and mild to moderate plaqu...
Eligibility Criteria
Inclusion
- Atopic Dermatitis (AD): Have been diagnosed with AD for at least 3 months; Have an Investigator's Global Assessment (IGA) score of 2 (mild), or 3 (moderate); Have AD covering 5% to 20% (inclusive) of BSA.
- Plaque psoriasis: Have been diagnosed with plaque psoriasis (psoriasis vulgaris) for at least 6 months; Have a Physician Global Assessment (PGA) score of 2 (mild), or 3 (moderate); Having plaque psoriasis covering 5% to 15% (inclusive) of BSA.
Exclusion
- Presence of skin comorbidities that would interfere with study assessment or response to treatment.
- Current or recent history of severe, progressive, or uncontrolled renal, hepatic, hematological, gastrointestinal, metabolic, endocrine, pulmonary, cardiovascular, or neurological disease.
- Other medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study.
Key Trial Info
Start Date :
December 21 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2021
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04664153
Start Date
December 21 2020
End Date
August 18 2021
Last Update
August 26 2022
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
First OC Dermatology
Fountain Valley, California, United States, 92708
2
Renaissance Research and Medical Group
Cape Coral, Florida, United States, 33991
3
Olympian Clinical Research
Clearwater, Florida, United States, 33756
4
Moonshine Research Center, Inc.
Doral, Florida, United States, 33166